Best Rate Direct

LONDON, Jan. 22, 2022 /PRNewswire/ — Opportunities in the digital asset market seem to pop up more frequently than ever recently. As a result, the popularity of derivatives, enabling quicker and more short-term actions in this market, has also risen. With that in mind, industry leading brand CryptGain has announced a new and attractive margin plan for all account holders. Users of the brand’s platform can find more details and register for the accounts on the brand’s website and this change is effective immediately.

“We know that margin is a key element of today’s financial online routine,” explained CryptGain’s spokesperson Georgina Skarginef, “and with that in mind we are updating our margin policy, making it even more attractive for our customers. We’re always on the lookout for ways to better the access we provide to the full potential of digital assets these days. We see great importance in margin in that sense, as a tool which can grant our clients more freedom to really explore the market.”

A reliable brand at your back

With the introduction of online activities based on derivatives of digital assets several years ago, competition between brands over clients has become intense. Having said that, CryptGain has managed to stay a leading force in this sector from its foundation. Margin loans are considered by many a tool which, when carefully used, can assist in discovering new opportunities.

“Our customers’ satisfaction has always been our number one goal,” added Skarginef. “We know that in today’s environment, enthusiasts of digital assets cannot really flourish without the concept of margins, and that’s why we put an emphasis on this aspect.”

About CryptGain

Established in the midst of the digital token revolution, CryptGain today is a key player among online financial services brands. This brokerage of digital assets provides its customers with mechanisms promising a fast, simple and secure experience when approaching the markets. The account type selection currently consists of three options: Silver, Gold and VIP. All account holders enjoy the margin benefit mentioned. When it comes to other features, such as seminars and portfolio managers, access depends on the size of the account chosen. All clients, whether account holders or not, have full access to support services which are granted through multiple means of communication, such as email, direct messaging system, and the onsite chat widget.

View original content:https://www.prnewswire.com/news-releases/cryptgain-introduces-attractive-margin-loans-to-account-holders-301464984.html

SOURCE CryptGain

LONDON, Jan. 22, 2022 /PRNewswire/ — The digital currency market is constantly reaching new volatility peaks since the beginning of 2022, and some analysts attribute it to the strengthening linkages between economies around the world. Therefore, those who conduct finances with these assets need to be more attentive to market movements around the clock. With that in mind, leading online firm Royal Bridge has announced a change to its operating hours, lengthening the time span in which support is granted to clients.

“We made a pledge to be there for our users whenever they need us, and we intend to stick to it,” remarked Royal Bridge’s spokesperson Gil McPhahrer. “We’ve been noticing more activity on our platform in GMT time early morning hours and late evening hours, and that’s why we’ve decided to take this step. Despite the extra costs we carry, we promise not to change our pricing to users, including any fee we currently charge.”

The importance of having someone to talk to

As of today, support is granted via several means of communication from 6 AM to 7 PM on weekdays, and from 6 AM to 4 PM on weekends, GMT. These means of communication include email, direct messaging, phone and the chat widget on the brand’s website. Royal Bridge currently benefits from positive feedback regarding the efficiency of its support staff, as is reflected in online reviews about the brand.

“When you get so many compliments from your clients, you know that you are doing something right,” added McPhahrer. “This motivates us to keep working hard on behalf of the users of our services. We want to thank them for putting their trust in us and to promise we will keep providing as much assistance and information as we can, especially in times of volatility like these.”

About Royal Bridge

Based in the UK and serving clients on a global scale, Royal Bridge has truly managed to bring a blessed change to the industry of online financial services. With professional know-how on digital assets, the brand’s team of account managers is always at clients’ side for any issue. The brand accepts deposits and conducts withdrawals through some of the most popular means today, including credit and debit cards, wire transfers, and an array of e-wallets. All transactions are committed under the strictest security and encryption protocols available today.

View original content:https://www.prnewswire.com/news-releases/royal-bridge-extends-support-hours-301465024.html

SOURCE Royal Bridge

NEW ORLEANS, Jan. 22, 2022 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into HP Inc. (NYSE: HPQ).  

In September of 2020, the U.S. Securities and Exchange Commission (“SEC”) issued a cease-and-desist order to the Company for its “failure to disclose between November 2015 and June 2016 material information regarding its print supplies channel inventory management and sales practices,” relating to a variety of tactics used to increase quarterly operating profit, while leading to “an erosion of profit margin and an increase in channel inventory.”  The SEC also announced that the Company had agreed to pay $6 million to settle the charges.

The Company has also been sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws, which remains ingoing.

KSF’s investigation is focusing on whether HP’s officers and/or directors breached their fiduciary duties to HP’s shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of HP shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-hpq/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com

1-877-515-1850

1100 Poydras St., Suite 3200

New Orleans, LA 70163

View original content to download multimedia:https://www.prnewswire.com/news-releases/hp-inc-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-hp-inc—hpq-301466101.html

SOURCE Kahn Swick & Foti, LLC

NEW ORLEANS, Jan. 22, 2022 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into QuantumScape Corporation (NYSE: QS).  

On January 4, 2021,  an investigative report issued by Seeking Alpha highlighted numerous measures of subpar performance discovered in the Company’s solid state battery products that rendered them “completely unacceptable for real world field electric vehicle performance,” contrary to the Company’s prior statements touting its battery’s performance data. The report also noted other significant challenges “to be overcome before they can put the first car in the field.”

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws. Recently, the court presiding over that case denied the Company’s motion to dismiss, allowing the case to move forward. 

KSF’s investigation is focusing on whether QuantumScape’s officers and/or directors breached their fiduciary duties to QuantumScape’s shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of QuantumScape shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-qs/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com

1-877-515-1850

1100 Poydras St., Suite 3200

New Orleans, LA 70163

View original content to download multimedia:https://www.prnewswire.com/news-releases/quantumscape-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-quantumscape-corporation—qs-301466100.html

SOURCE Kahn Swick & Foti, LLC

NEW YORK, Jan. 21, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of FirstCash, Inc. (“FirstCash” or the “Company”) (NASDAQ: FCFS).   Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether FirstCash and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On November 12, 2021, the Consumer Financial Protection Bureau (“CFPB”) filed a lawsuit against FirstCash and Cash America West, alleging that the two companies violated the Military Lending Act by charging higher than the allowable 36% annual rate on pawn loans to active-duty service members and their dependents.  The CFPB’s lawsuit seeks an injunction, redress for affected borrowers, and a civil money penalty. 

On this news, FirstCash’s stock price fell $7.50 per share, or 8.71%, to close at $78.64 per share on November 12, 2021.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com 

888-476-6529 ext. 7980

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-firstcash-inc—fcfs-301466080.html

SOURCE Pomerantz LLP

NEW YORK, Jan. 21, 2022 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP; NRXPW) and certain of its officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 22-cv-00066, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired NRx securities between June 1, 2021 and November 4, 2021, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased or otherwise acquired NRx during the Class Period, you have until March 21, 2022 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here for information about joining the class action]

NRx is a clinical-stage small molecule pharmaceutical company that develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The Company’s products include, among others, ZYESAMI, an investigational pre-commercial drug for COVID-19 related respiratory failure.

In June 2021, NRx announced that it filed an application with U.S. Food and Drug Administration (“FDA”) requesting Emergency Use Authorization (“EUA”) for ZYESAMI (Aviptadil-acetate) to treat critically ill COVID-19 patients suffering with respiratory failure (the “ZYESAMI EUA Application”).

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the ZYESAMI EUA Application contained insufficient data regarding the potential benefits and risks of ZYESAMI; (ii) accordingly, the FDA was unlikely to approve the ZYESAMI EUA Application in its present form; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On November 4, 2021, NRx issued a press release “announc[ing] that the [FDA] has declined to issue an [EUA] for ZYESAMI^® (aviptadil). The FDA stated that it was unable to issue the EUA at this time due to insufficient data regarding the known and potential benefits of the medicine and the known and potential risks of ZYESAMI in patients suffering from Critical COVID-19 with respiratory failure.”

On this news, NRx’s stock price fell $2.27 per share, or 25.45%, to close at $6.65 per share on November 5, 2021.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com 

888-476-6529 ext. 7980

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-nrx-pharmaceuticals-inc-of-class-action-lawsuit-and-upcoming-deadline–nrxp-nrxpw-301466010.html

SOURCE Pomerantz LLP

DALLAS, Jan. 21, 2022 /PRNewswire/ — NexPoint Real Estate Finance, Inc. (NYSE: NREF) (“NREF” or the “Company”) announced today the pricing of its underwritten public offering of $35 million aggregate principal amount of its 5.75% Senior Unsecured Notes due 2026 (the “Additional Notes”). The Additional Notes were issued at a price of 100.875% of par with a yield to maturity of 5.514%. The Additional Notes are an additional issuance of the Company’s existing $135 million aggregate principal amount of its 5.75% Senior Unsecured Notes due 2026 (the “Existing Notes”) and the Additional Notes will be issued under the same indenture as the Existing Notes, will be treated as a single class of debt securities with the Existing Notes and will have the same terms as the Existing Notes, other than the issue date and offering price. The offering is expected to close on or about January 25, 2022, subject to customary closing conditions.

The Company intends to contribute the net proceeds from this offering to its operating partnership, NexPoint Real Estate Finance Operating Partnership, L.P. (the “OP”), in exchange for OP units. The OP intends to use the net proceeds from this offering to acquire several pipeline investments which are expected to close in the foreseeable future. These investments consist of multifamily, life sciences and hospitality debt and preferred positions offering attractive risk adjusted returns supported by strong, experienced, and well-known sponsors.

Raymond James is acting as sole book-running manager for the offering. The Company is making this offering pursuant to a shelf registration statement that became effective on March 31, 2021. This offering will be made solely by means of a prospectus and prospectus supplement, copies of which may be obtained from Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, telephone (800) 248-8863, email: prospectus@raymondjames.com or through the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Additional Notes, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

About NexPoint Real Estate Finance, Inc.

NexPoint Real Estate Finance, Inc. is a publicly traded REIT with its shares listed on the New York Stock Exchange under the symbol “NREF.”  NREF is primarily focused on originating, structuring and investing in first mortgage loans, mezzanine loans, preferred equity and alternative structured financings in commercial real estate properties, as well as multifamily commercial mortgage backed securities.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management’s current expectations, assumptions and beliefs. Forward-looking statements can often be identified by words such as “anticipate,” “estimate,” “expect,” “intend,” “may,” “should” and similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding the intended use of proceeds and the closing of the Additional Notes offering. They are not guarantees of future results and forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statement, including the ultimate duration and severity of the COVID-19 pandemic, and the effectiveness of actions taken, or actions that may be taken, by governmental authorities to contain the outbreak or treat its impact, as well as those described in greater detail in our filings with the Securities and Exchange Commission (the “SEC”), particularly those described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.  Readers should not place undue reliance on any forward-looking statements and are encouraged to review NREF’s other filings with the SEC for a more complete discussion of risks and other factors that could affect any forward-looking statement. The statements made herein speak only as of the date of this press release and except as required by law, NREF does not undertake any obligation to publicly update or revise any forward-looking statements.

Contact:

NexPoint Real Estate Finance, Inc.

Investor Relations

Jackie Graham

JGraham@nexpoint.com

833.463.6697

View original content:https://www.prnewswire.com/news-releases/nexpoint-real-estate-finance-inc-announces-pricing-of-35-million-offering-of-5-75-senior-unsecured-notes-due-2026–301466068.html

SOURCE NexPoint Real Estate Finance, Inc.

TALLAHASSEE, Fla., Jan. 21, 2022 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced that it publicly filed a resale registration on Form S-1 (the “Registration Statement”) with the United States Securities and Exchange Commission (“SEC”) on January 21, 2022 to register for resale Subordinate Voting Shares of the Company issued as consideration for previously announced 2021 acquisitions. 

In 2021, the Company completed the acquisition of: (i) certain assets from each of Patient Centric of Martha’s Vineyard Ltd. (PCMV) and Nature’s Remedy of Massachusetts, Inc. (Nature’s Remedy) and (ii) all of the outstanding equity of Anna Holdings LLC (Keystone Shops), Mountaineer Holding, LLC (Mountaineer) and Solevo West Virginia LLC (Solevo West Virginia). In connection with and as consideration for these acquisitions, the Company issued an aggregate of 1,577,600 of its Subordinate Voting Shares to certain stakeholders (the “Selling Shareholders”). 

The Selling Shareholders may offer, sell or distribute all or a portion of their Subordinate Voting Shares publicly or through private transactions at prevailing market prices or at negotiated prices. However, the registration of the securities covered by the Registration Statement does not necessarily indicate that the Selling Shareholders will offer or sell any Subordinate Voting Shares in connection with such registration or within any specific timeframe.

On January 21, 2022, the Company also filed a post-effective amendment to its existing Resale Registration Statement on Form S-1, as amended (the “Existing Resale Registration Statement”), covering the resale of certain securities of the Company. The amendment was filed to update the Existing Registration Statement to include unaudited interim financial statements of Trulieve and certain information regarding Trulieve’s acquisition of Harvest Health & Recreation Inc. No additional securities were registered for resale by the selling shareholders under the Existing Registration Statement (the “Existing Selling Shareholders”) under the Post-Effective Amendment.

The Company is not selling any Subordinate Voting Shares under the Registration Statement or the Existing Registration Statement and will not receive any proceeds from the sale of Subordinate Voting Shares by the Selling Shareholders under the Registration Statement or by the Existing Selling Shareholders under the Existing Registration Statement, as amended. Each of the Registration Statement and the post-effective amendment to the Existing Registration Statement relating to the securities described above have been filed with the SEC but have not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that each of the Registration Statement and the Existing Registration Statement, as amended by the post-effective amendment, becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

About Trulieve

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve

Instagram: @Trulieve 

Twitter: @Trulieve  

Investor Contact

Christine Hersey, Director of Investor Relations

+1 (424) 202-0210

Christine.Hersey@Trulieve.com 

Media Contact

Rob Kremer, Executive Director of Corporate Communications

+1 (404) 218-3077

Robert.Kremer@Trulieve.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-resale-registration-statement-filings-301466061.html

SOURCE Trulieve Cannabis Corp.

NEW YORK, Jan. 21, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Embark Technology, Inc. (“Embark” or the “Company”) (NASDAQ: EMBK).   Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Embark and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On January 6, 2022, The Bear Cave published a short report entitled “Problems at Embark Technology (EMBK”) (the “Bear Cave Report”).  The Bear Cave Report alleged, among other issues, “that Embark appears to lack true economic substance” and that its “current evaluation appears to be based on puffery rather than actual substance”, noting that “[t]he company holds no patents, has only a dozen or so test trucks, and may be more bark than bite.” 

On this news, Embark’s stock price fell $1.37 per share, or 16.75%, to close at $6.81 per share on January 6, 2022.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com 

888-476-6529 ext. 7980

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-embark-technology-inc—embk-301465981.html

SOURCE Pomerantz LLP

CAMAS, Wash., Jan. 21, 2022 /PRNewswire/ — Fisher Investments, one of the world’s largest independent, fee-only investment advisers, was named a 2021 Citywire France Best Global Equity-Blend Strategy Manager. Citywire France recognizes investment managers in specific categories available to French institutional investors over the past three years (to August 31, 2021).

Citywire France evaluated thousands of investment manager teams to choose the winners. The evaluation process considers managers’ combined experience, strategy assets under management, consistency of benchmark-relative performance—among other factors.

“We’re once again honored the Citywire organization recognized our Investment Policy Committee for their experience and success in managing institutional global equity strategies,” said Fisher Investments’ CEO Damian Ornani. “A diversified, global investing approach is a core tenet of our investment philosophy, so it’s exciting to be recognized again for this strategy and the value it provides our clients.”

“We are thrilled to be recognized by such a highly respected organization, especially given their rigorous, analytical process and deep knowledge of our investment strategy,” added Justin Arbuckle, Senior Executive Vice President of Fisher Investments’ Institutional Group.

For more information about Fisher Investments, please visit www.fisherinvestments.com.

About Fisher Investments                                                                

Fisher Investments is an independent, fee-only investment adviser. As of 12/31/2021, Fisher Investments and its subsidiaries manage over $208 billion in assets globally—over $163 billion for private investors, $42 billion for institutional investors and $2 billion for US small to mid-sized business retirement plans.  Fisher Investments maintains four principal business groups: US Private Client, Institutional, Private Client International and 401(k) Solutions, which serve a global client base of diverse investors. Founder and Executive Chairman Ken Fisher wrote the Forbes “Portfolio Strategy” column from 1984 through 2016, making him the longest continuously running columnist in the magazine’s history. In recent years, Ken’s columns have run consistently in major media outlets across almost every Western European country as well as material Asian countries, spanning more countries and more volume than any other columnist of any type in history. Ken has also authored 11 books, including four New York Times bestsellers on finance and investing. For more information, please visit www.fisherinvestments.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fisher-investments-earns-citywire-france-global-equity-blend-strategy-award-301466048.html

SOURCE Fisher Investments